Four Ipsen colleagues discuss the fabric and value of high-performing teams, especially against the backdrop of COVID-19.

Uzair Qadeer, Chief Diversity Officer, Alexion, discusses his notable career as an HR futurist, plus diversity and belonging in pharma.

Kevin O’Brien, President, North America, Merz Therapeutics, talks about the intricacies of developing a treatment for a new indication.

Ester Banque, Senior Vice President and Head of Intercontinental Commercial, BMS, talks about her unique approach to leadership.

Kay Wesley, Chief Executive, Kanga Health, talks about pharma’s digital transformation and her passion for creating gender equality.

Nancy Globus, Vice President for Regulatory and Medicine Safety, Addison Whitney, talks medication safety, product labelling and errors.

Looking forward to the year ahead, GOLD casts five predictions for what the standout advancements and priorities will be for pharma in 2021.

Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.